TickerFacts.

Exagen Inc. (XGN): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$13.62M
Year ended 2025-12-31
-$6.50M
Trailing 12 months to 2026-06-30
2018-12-31: -$9.30M2019-12-31: -$9.71M2020-12-31: -$14.08M2021-12-31: -$20.27M2022-12-31: -$32.14M2023-12-31: -$14.46M2024-12-31: -$13.28M2025-12-31: -$13.62M-$13.62M
2018-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$13.62Mn/m2026-03-10, From 2025-01-01
2024-12-31-$13.28Mn/m2026-03-10, From 2024-01-01
2023-12-31-$14.46Mn/m2025-03-11, From 2023-01-01
2022-12-31-$32.14Mn/m2024-03-18, From 2022-01-01
2021-12-31-$20.27Mn/m2023-03-20, From 2021-01-01
2020-12-31-$14.08Mn/m2022-03-22, From 2020-01-01
2019-12-31-$9.71Mn/m2021-03-16, From 2019-01-01
2018-12-31-$9.30Mn/a2020-03-25, From 2018-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Exagen Inc. (XGN)2025-12-31-$13.62Mn/m
Personalis, Inc. (PSNL)2025-12-31-$74.95Mn/m
Biodesix Inc (BDSX)2025-12-31-$23.27Mn/m
CapForce Inc. (CFOR)2025-12-31-$1.18Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$299.01Mn/m
American Shared Hospital Services (AMS)2025-12-31$3.10Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$24.59Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$101.64Mn/m
Castle Biosciences Inc (CSTL)2025-12-31$64.35M-0.8%

Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗